69 related articles for article (PubMed ID: 17962207)
1. Central nervous system involvement in mantle cell lymphoma.
Ferrer A; Bosch F; Villamor N; Rozman M; Graus F; Gutiérrez G; Mercadal S; Campo E; Rozman C; López-Guillermo A; Montserrat E
Ann Oncol; 2008 Jan; 19(1):135-41. PubMed ID: 17962207
[TBL] [Abstract][Full Text] [Related]
2. Testicular involvement in mantle cell lymphoma: An analysis of 16 patients.
Alkhalili S; Manogna D; Safah H; Ellent E; Beversdorf W; Arora R; Saba NS
Leuk Res Rep; 2023; 20():100397. PubMed ID: 38053743
[TBL] [Abstract][Full Text] [Related]
3. Complete response of mantle cell lymphoma with central nervous system involvement at diagnosis with acalabrutinib - Case report.
Barrett A; Eyre TA; Bhuva S; Aljurf M; Fakih RE; Ashshi MA; Alshaibani A
EJHaem; 2024 Feb; 5(1):238-241. PubMed ID: 38406527
[TBL] [Abstract][Full Text] [Related]
4. Central nervous system involvement in multiple myeloma: Experience from a tertiary cancer center and review of literature.
Jain K; Bommannan K; Ganesan P; Arumugam JR; Sagar TG; Sundersingh S
Indian J Cancer; 2023 Apr; ():. PubMed ID: 38090956
[TBL] [Abstract][Full Text] [Related]
5. Central nervous system involvement of mantle cell lymphoma: Case report and review of the literature.
Ağargün BF; Özbalak M; Gülseren ÜA; Yegen G; Beşışık SK
Hematol Transfus Cell Ther; 2022 Dec; ():. PubMed ID: 36481200
[No Abstract] [Full Text] [Related]
6. Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network.
Cheah CY; George A; Giné E; Chiappella A; Kluin-Nelemans HC; Jurczak W; Krawczyk K; Mocikova H; Klener P; Salek D; Walewski J; Szymczyk M; Smolej L; Auer RL; Ritchie DS; Arcaini L; Williams ME; Dreyling M; Seymour JF;
Ann Oncol; 2013 Aug; 24(8):2119-23. PubMed ID: 23616279
[TBL] [Abstract][Full Text] [Related]
7. Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma.
Robak T; Huang H; Jin J; Zhu J; Liu T; Samoilova O; Pylypenko H; Verhoef G; Siritanaratkul N; Osmanov E; Alexeeva J; Pereira J; Drach J; Mayer J; Hong X; Okamoto R; Pei L; Rooney B; van de Velde H; Cavalli F;
N Engl J Med; 2015 Mar; 372(10):944-53. PubMed ID: 25738670
[TBL] [Abstract][Full Text] [Related]
8. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma.
Fernàndez V; Salamero O; Espinet B; Solé F; Royo C; Navarro A; Camacho F; Beà S; Hartmann E; Amador V; Hernández L; Agostinelli C; Sargent RL; Rozman M; Aymerich M; Colomer D; Villamor N; Swerdlow SH; Pileri SA; Bosch F; Piris MA; Montserrat E; Ott G; Rosenwald A; López-Guillermo A; Jares P; Serrano S; Campo E
Cancer Res; 2010 Feb; 70(4):1408-18. PubMed ID: 20124476
[TBL] [Abstract][Full Text] [Related]
9. CNS involvement in mantle-cell lymphoma.
Montserrat E; Bosch F; López-Guillermo A; Graus F; Terol MJ; Campo E; Rozman C
J Clin Oncol; 1996 Mar; 14(3):941-4. PubMed ID: 8622043
[TBL] [Abstract][Full Text] [Related]
10. Ibrutinib Treatment of Mantle Cell Lymphoma Relapsing at Central Nervous System: A Case Report and Literature Review.
Mannina D; Loteta B
Case Rep Hematol; 2017; 2017():9583257. PubMed ID: 28791187
[TBL] [Abstract][Full Text] [Related]
11. Mantle Cell Lymphoma with Central Nervous System Involvement Simulating Bilateral Subdural Hematomas.
González-Bonet LG; García-Boyero R; Gaona-Morales J
World Neurosurg; 2017 Mar; 99():808.e1-808.e2. PubMed ID: 28063897
[TBL] [Abstract][Full Text] [Related]
12. Mantle cell lymphoma with central nervous system involvement: frequency and clinical features.
Gill S; Herbert KE; Prince HM; Wolf MM; Wirth A; Ryan G; Carney DA; Ritchie DS; Davies JM; Seymour JF
Br J Haematol; 2009 Oct; 147(1):83-8. PubMed ID: 19694718
[TBL] [Abstract][Full Text] [Related]
13. Ki-67 is a strong predictor of central nervous system relapse in patients with mantle cell lymphoma (MCL).
Chihara D; Asano N; Ohmachi K; Nishikori M; Okamoto M; Sawa M; Sakai R; Okoshi Y; Tsukamoto N; Yakushijin Y; Nakamura S; Kinoshita T; Ogura M; Suzuki R
Ann Oncol; 2015 May; 26(5):966-973. PubMed ID: 25712457
[TBL] [Abstract][Full Text] [Related]
14. Paraneoplastic neurological syndromes of the central nervous system: a single institution 7-year case series.
Giammello F; Galletta K; Grillo F; Brizzi T; Cavallaro M; Mormina E; Scelzo E; Allegra C; Stancanelli C; Rodolico C; Musumeci O; Toscano A; Granata F
Acta Neurol Belg; 2023 Aug; 123(4):1355-1369. PubMed ID: 36884202
[TBL] [Abstract][Full Text] [Related]
15. CAR T-cell therapy for mantle cell lymphoma with central nervous system relapse.
Vu K; Frank MJ
Blood Adv; 2023 Feb; 7(3):375-378. PubMed ID: 35895518
[No Abstract] [Full Text] [Related]
16. Symptomatic leptomeningeal carcinomatosis: a rare presentation of chronic lymphocytic leukaemia relapse.
Batayneh O; Lin A; Abu-Jaradeh O; Wu P; Villamar MF; Sharma P
BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35675961
[TBL] [Abstract][Full Text] [Related]
17. Rare central nervous system lymphomas.
Kaji FA; Martinez-Calle N; Sovani V; Fox CP
Br J Haematol; 2022 Jun; 197(6):662-678. PubMed ID: 35292959
[TBL] [Abstract][Full Text] [Related]
18. Bilateral vision loss as the initial presentation for central nervous system involvement of mantle cell lymphoma: A case series.
Small L; Ma C; Shah M; Ramanathan S; Rasool N
Am J Ophthalmol Case Rep; 2021 Sep; 23():101131. PubMed ID: 34151045
[TBL] [Abstract][Full Text] [Related]
19. Palatine Tonsils Primary Presentation of Blastoid Variant of Mantle Cell Lymphoma: Case Report.
Marques JAS; Ferreira F; Melo DP; Santos M; Vaz RP
Head Neck Pathol; 2021 Jun; 15(2):588-592. PubMed ID: 33091144
[TBL] [Abstract][Full Text] [Related]
20. Complete remission with ibrutinib after allogeneic stem cell transplant for central nervous system relapse of mantle cell lymphoma: A case report and literature review.
Rich JD; Clark SM; Fedoriw Y; Jewells V; Wood W; Dittus C
Clin Case Rep; 2019 Oct; 7(10):1957-1961. PubMed ID: 31624617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
